Search

everythinglearnresearchcommunity

for

Search:↓

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by affecting androgen functions and suppressing certain hormones.

HDMHG0401-10 treatment significantly improved hair count and was better than a placebo in reducing hair loss in men with hereditary hair loss, with no major side effects.

New compounds similar to cromakalim were less effective at inhibiting insulin release but improved in solubility and one acted as a calcium entry blocker, not a potassium channel opener.

Essential oils from Hedychium spicatum have potential for developing natural drugs with pain-blocking, fever-reducing, anti-inflammatory, and antioxidant properties.

HtrA2 activity is crucial for normal hair growth by regulating fat cell development.

Some herbs show promise as antiandrogenic agents.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

5-alpha reductase inhibitors slightly increase depression risk, but the risk varies based on the control group used.

Cetirizine-loaded gel may effectively promote hair growth in alopecia.

Asiasari radix extract may relieve certain types of pain by affecting GABA and NMDA receptors.

Anabolic steroids and SARMs can cause serious liver damage.

Neuroactive steroids affect cocaine's rewarding effects through the sigma1 receptor.

Females had more chemotherapy side effects than males, with many being preventable.

Polyamines are important in deciding hair follicle stem cell behavior, affecting hair growth and loss.

The document concludes that various drugs for men's health issues are in development, with treatments for sexual dysfunction and prostate conditions being the most advanced.

HDMHG0401-10 improves hair loss in men with androgenetic alopecia and has no major side effects.

Male hormones and reduced plakoglobin can impair heart electrical function and increase arrhythmia risk in males.

Mutants of CYP154C2 enzyme significantly improved steroid conversion efficiency.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Auranofin shows promise as a cancer treatment, especially when combined with other therapies.

Finasteride may affect brain chemistry and behavior, offering potential for treating certain mental health conditions.

Dextroamphetamine may help treat alopecia areata.

DHA-NLC may improve drug delivery and reduce side effects for cancer treatment.

A new nanozyme using EGCG and L-arginine boosts hair growth by safely increasing beneficial oxidative stress.